The staff is very nice and helpful
Oral supplements and topical products can also be used but may take longer to show visible effects
While NAD+ IV therapy is safe for most individuals, it may not be suitable in the following cases: Known allergy to NAD+ (oral or IV forms) Pregnant or breastfeeding individuals People taking immunosuppressant medications Patients currently undergoing chemotherapy or radiotherapy If youre unsure whether NAD+ therapy is right for you, we offer a free consultation with our medical team to evaluate your eligibility and tailor a safe, effective treatment plan
The following incidences of primary carnitine deficiency in newborns have been reported: 1:40,000 in Japan [70], 1:37,0001:100,000 in Australia [71], 1:105,000 in Portugal [72], 1:142,000 in the USA [73], 1:250,000 in Germany [74] and 1:297 in the Faroe islands [68]
Jenny H.Y
Accessed 11 June 2026